High Protein Diet Achieves 100% Prediabetes Remission by Boosting GLP-1 and GIP Peptide Hormones

A high protein diet achieved 100% prediabetes remission (vs 33% for high carb) by boosting the incretin peptides GLP-1 and GIP while suppressing the hunger hormone ghrelin.

Stentz, Frankie B et al.·Nutrition·2021·Moderate EvidenceRandomized Controlled Trial
RPEP-05790Randomized Controlled TrialModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Randomized Controlled Trial
Evidence
Moderate Evidence
Sample
N=24 participants
Participants
24 obese adults with prediabetes randomized to high protein or high carbohydrate diet for 6 months with all food provided

What This Study Found

High protein diet achieved 100% prediabetes remission vs 33% on high carb diet, with significantly greater increases in GLP-1 and GIP AUC, greater ghrelin suppression, and improved BNP over 6 months.

Key Numbers

24 participants; 100% vs 33% prediabetes remission; GLP-1 AUC p=0.001; GIP AUC p=0.005; ghrelin AUC p=0.001-0.005; BNP p=0.001; similar weight loss between groups

How They Did This

Randomized controlled trial. 24 obese adults with prediabetes. High protein (n=12) vs high carbohydrate (n=12) diet for 6 months with all food provided. OGTT and MTT measured GLP-1, GIP, ghrelin, BNP, insulin, glucose at baseline and 6 months.

Why This Research Matters

Prediabetes affects hundreds of millions of people globally. Achieving 100% remission with diet alone, through a mechanism involving satiety and incretin hormones, could prevent millions of diabetes cases.

The Bigger Picture

This study provides a fascinating dietary parallel to the GLP-1 drug revolution. While drugs like semaglutide and tirzepatide achieve their effects by mimicking GLP-1 and GIP pharmacologically, this study shows that dietary composition can naturally boost these same peptides. The finding that protein preferentially stimulates incretins and suppresses ghrelin suggests that diet optimization could complement or potentially reduce the need for expensive peptide drug therapy in some patients.

What This Study Doesn't Tell Us

Very small study (24 participants). All food was provided, which is not practical long-term. Six months may not predict lasting remission. No long-term follow-up. The HP and HC diets differed in multiple ways, not just protein content.

Questions This Raises

  • ?Could combining a high-protein diet with low-dose GLP-1 agonists produce synergistic metabolic benefits?
  • ?Do the incretin hormone improvements from high-protein diets persist long-term after participants return to self-selected diets?
  • ?Which specific proteins or amino acids are most responsible for stimulating GLP-1 and GIP release?

Trust & Context

Key Stat:
100% vs 33% prediabetes remission High protein diet achieved complete prediabetes reversal in all participants, partly through naturally boosting the same incretin peptides (GLP-1, GIP) that blockbuster diabetes drugs target pharmacologically.
Evidence Grade:
This is a small randomized controlled trial (n=24) with a registered protocol and all food provided, ensuring dietary compliance. The randomized design supports causal conclusions, but the very small sample size limits generalizability. The 100% remission rate may not replicate in larger, more diverse populations.
Study Age:
Published in 2021, this study provides evidence connecting dietary composition to incretin peptide release at a time when GLP-1 RA drugs were rapidly expanding.
Original Title:
High protein diet leads to prediabetes remission and positive changes in incretins and cardiovascular risk factors.
Published In:
Nutrition, metabolism, and cardiovascular diseases : NMCD, 31(4), 1227-1237 (2021)
Database ID:
RPEP-05790

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled TrialGold standard for testing treatments
This study
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Participants are randomly assigned to treatment or placebo groups to test cause and effect.

What do these levels mean? →

Frequently Asked Questions

How does eating more protein boost GLP-1 and GIP?

When protein is digested, amino acids stimulate specialized cells in the gut lining (L-cells and K-cells) that produce GLP-1 and GIP. These incretin peptides then signal the pancreas to release insulin more effectively, slow stomach emptying to increase fullness, and tell the brain to reduce appetite. Protein is a stronger stimulus for these peptides than carbohydrates, which is why the high-protein diet produced larger incretin responses.

If diet can boost GLP-1 naturally, why do people need GLP-1 drugs?

The natural GLP-1 boost from diet is modest and short-lived — it lasts minutes after a meal. GLP-1 drugs like semaglutide provide sustained, much higher levels of receptor activation around the clock for days. However, this study suggests diet optimization can complement drug therapy and may be sufficient for some patients with prediabetes. For those with established diabetes or severe obesity, the pharmacological approach provides a far more powerful effect.

Read More on RethinkPeptides

Cite This Study

RPEP-05790·https://rethinkpeptides.com/research/RPEP-05790

APA

Stentz, Frankie B; Mikhael, Andrew; Kineish, Omer; Christman, John; Sands, Chris. (2021). High protein diet leads to prediabetes remission and positive changes in incretins and cardiovascular risk factors.. Nutrition, metabolism, and cardiovascular diseases : NMCD, 31(4), 1227-1237. https://doi.org/10.1016/j.numecd.2020.11.027

MLA

Stentz, Frankie B, et al. "High protein diet leads to prediabetes remission and positive changes in incretins and cardiovascular risk factors.." Nutrition, 2021. https://doi.org/10.1016/j.numecd.2020.11.027

RethinkPeptides

RethinkPeptides Research Database. "High protein diet leads to prediabetes remission and positiv..." RPEP-05790. Retrieved from https://rethinkpeptides.com/research/stentz-2021-high-protein-diet-leads

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.